Baroreflex activation for arrhythmia treatment

• US 20060004417A1
• Filed: 06/27/2005
• Published: 01/05/2006
• Est. Priority Date: 06/30/2004
• Status: Abandoned Application

• Current Assignee: CVRx, Inc.
• Original Assignee: CVRx, Inc.
• Inventors: Serdar, David J., Rossing, Martin A., Kieval, Robert S., Irwin, Eric D., Martin, Roy C.
• Application Number:
  US11/168,231
• Publication Number:
  US 20060004417A1
• Time in Patent Office: Days
• US Class Current: 607/9
• CPC Class Codes: A61N 1/0556 Cuff electrodes
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362

Abstract

Devices, systems and methods provide baroreflex activation to prevent, or at least reduce the likelihood of occurrence of, cardiac arrhythmias. Various embodiments may additionally or alternatively promote recovery from arrhythmias. In one embodiment, a device for preventing or reducing the likelihood of occurrence of arrhythmias includes one or more baroreflex activation devices, one or more sensors coupled to the baroreflex activation device(s), and a processor for processing information from the sensor and activating and/or modulation the baroreflex activation device. Sensors, such as electrocardiogram devices, generally sense factors indicative of a potential, ensuing arrhythmia.

Claims

1. A method for preventing or reducing the likelihood of occurrence of an arrhythmia in a heart of a patient, the method comprising activating a baroreflex system of the patient with at least one baroreflex activation device.

2. A method as in claim 1, wherein activating the baroreflex system comprises activating at least one of a baroreceptor, one or more nerves coupled with a baroreceptor, and a carotid sinus nerve.

3. A method as in claim 2, wherein activating comprises activating at least one baroreceptor is activated.

4. A method as in claim 3, wherein the baroreceptor is located in at least one of a carotid sinus, aortic arch, heart, common carotid artery, subclavian artery, and brachiocephalic artery.

5. A method as in claim 3, wherein the baroreceptor is located in at least one of an inferior vena cava, superior vena cava, portal vein, jugular vein, subclavian vein, iliac vein and femoral vein.

6. A method as in claim 1, wherein baroreflex activation device is implanted in the patient.

7. A method as in claim 1, wherein activating comprises at least one of electrical activation, mechanical activation, thermal activation and chemical activation.

8. A method as in claim 1, wherein activating comprises at least one of continuous activation, pulsed activation and periodic activation.

9. A method as in claim 1, further comprising:

sensing a patient condition indicative of an arrhythmia; and

initiating or modifying activation of the baroreflex in response to the sensed patient condition.

10. A method as in claim 9, wherein sensing the patient condition comprises sensing physiological activity with one or more sensors.

11. A method as in claim 10, wherein sensing is performed with at least one device selected from the group consisting of an extracardiac electrocardiogram, an intracardiac electrocardiogram, a pressure sensor and an accelerometer.

12. A method as in claim 10, wherein the sensed patient condition comprises a change in heart rate.

13. A method as in claim 10, wherein the sensed patient condition comprises a change in relative timing of atrial and ventricular contractions.

14. A method as in claim 10, wherein the sensed patient condition comprises a change in a T-wave on an electrocardiogram.

15. A method as in claim 10, wherein the sensed patient condition comprises a change in an S-T segment shape on an electrocardiogram.

16. A method as in claim 10, wherein sensing comprises acquiring pressure data from the patient'"'"'s heart.

17. A method as in claim 16, further comprising converting the pressure data into cardiac performance data.

18. A method as in claim 9, wherein modifying comprises increasing activation of the baroreflex.

19. A method as in claim 1, wherein activating is controlled by the patient.

20. A method as in claim 1, further comprising modifying activation of the baroreflex during and/or after anti-arrhythmia pacing is applied to the heart via a pacemaker.

21. A method as in claim 1, further comprising modifying activation of the baroreflex during and/or after anti-arrhythmia treatment is applied to the heart via a cardiovertor/defibrillator.

22. A method for preventing or reducing the likelihood of occurrence of an arrhythmia in a heart of a patient, the method comprising:

activating a baroreflex system of the patient with at least one baroreflex activation device;

sensing a patient condition indicative of an arrhythmia; and

modifying activation of the baroreflex in response to the sensed patient condition.

23. A method as in claim 22, wherein sensing the patient condition comprises sensing physiological activity with one or more sensors.

24. A method as in claim 23, wherein sensing is performed with at least one device selected from the group consisting of an extracardiac electrocardiogram, an intracardiac electrocardiogram, a pressure sensor and an accelerometer.

25. A method as in claim 23, wherein the sensed patient condition comprises a change in heart rate.

26. A method as in claim 23, wherein the sensed patient condition comprises a change in relative timing of atrial and ventricular contractions.

27. A method as in claim 23, wherein the sensed patient condition comprises a change in a T-wave on an electrocardiogram.

28. A method as in claim 23, wherein the sensed patient condition comprises a change in an S-T segment shape on an electrocardiogram.

29. A method as in claim 23, wherein sensing comprises acquiring pressure data from the patient'"'"'s heart.

30. A method as in claim 29, further comprising converting the pressure data into cardiac performance data.

31. A method as in claim 22, wherein modifying comprises increasing activation of the baroreflex.

32. A method as in claim 22, further comprising modifying activation of the baroreflex during and/or after anti-arrhythmia pacing is applied to the heart via a pacemaker.

33. A method as in claim 22, further comprising modifying activation of the baroreflex during and/or after anti-arrhythmia treatment is applied to the heart via a cardiovertor/defibrillator.

34. A method for promoting recovery from an arrhythmia in a heart of a patient, the method comprising modifying an intensity of baroreflex activation during and/or after an anti-arrhythmia pacing therapy is applied to the heart via a pacemaker.

35. A method for promoting recovery from an arrhythmia in a heart of a patient, the method comprising modifying an intensity of baroreflex activation during and/or after an anti-arrhythmia pacing therapy is applied to the heart via a cardioverter/defibrillator.

36. A method for preventing and/or treating chronic heart failure in a patient, the method comprising:

activating a baroreflex system of the patient with at least one baroreflex activation device;

sensing a patient condition indicative of chronic heart failure; and

modifying activation of the baroreflex in response to the sensed patient condition.

37. A device or system for preventing, reducing the likelihood of occurrence of and/or promoting recovery from an arrhythmia in a heart of a patient, the device comprising:

at least one baroreflex activation device;

at least one sensor; and

a processor coupled with the at least one baroreflex activation device and the at least one sensor for processing sensed data received from the sensor and for activating and/or modifying activation of baroreflex activation device in response to the sensed data.

38. A device as in claim 37, wherein the device is implantable within the patient.

39. A device as in claim 38, wherein the device is implantable within venous or arterial vasculature.

40. A device as in claim 37, wherein the at least one sensor comprises at least one physiological sensor.

41. A device as in claim 40, wherein the at least one sensor is selected from the group consisting of an electrocardiogram, a pressure sensing device, a blood pressure sensor and an accelerometer.

42. A device as in claim 40, wherein the sensor is adapted to sense at least one of an intracardiac pressure, a heart rate and a timing of contractions of atria and ventricles of the heart.

43. A device as in claim 37, further comprising an anti-arrhythmia pacemaker device coupled with the processor, wherein the processor processes information regarding activation of the pacemaker and modifies activation of baroreflex activation device when the pacemaker is activated.

44. A device as in claim 37, further comprising a cardiovertor/defibrillator device coupled with the processor, wherein the processor processes information regarding activation of the cardiovertor/defibrillator and modifies activation of baroreflex activation device when the cardiovertor/defibrillator is activated.